EMAS position statement: Testosterone replacement therapy in the aging male

Dimopoulou, Christina; Ceausu, Iuliana; Depypere, Herman; Lambrinoudaki, Irene; Mueck, Alfred; Perez-Lopez, Faustino; Rees, Margaret; van der Schouw, Yvonne; Senturk, Levent; Simonsini, Tommaso; Stevenson, John; Stute, Petra; Goulis, Dimitrios

doi:10.1016/j.maturitas.2015.11.003

EMAS position statement: Testosterone replacement therapy in the aging male

Copy For Citation

Dimopoulou C., Ceausu I., Depypere H., Lambrinoudaki I., Mueck A., Perez-Lopez F. R., ...More

MATURITAS, vol.84, pp.94-99, 2016 (SCI-Expanded)

Publication Type: Article / Article
Volume: 84
Publication Date: 2016
Doi Number: 10.1016/j.maturitas.2015.11.003
Journal Name: MATURITAS
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.94-99
Istanbul University Affiliated: Yes

Abstract

Introduction: Late-onset hypogonadism (LOH) represents a common clinical entity in aging males, characterized by the presence of symptoms (most usually of a sexual nature, such as decreased libido, decreased spontaneous erections and erectile dysfunction) and signs, in combination with low serum testosterone concentrations. Whether testosterone replacement therapy (TRT) should be offered to those individuals is still under extensive debate.